Ex Parte SHOEMAKER - Page 8




          Appeal No. 2003-2062                                                        
          Application 09/853,568                                                      


          information to be displayed, and also invoked the “printed                  
          matter” doctrine to dispose of these claims (answer, pages 4-5),            
          we find no need to resort to such approaches, since Mayfield                
          alone discloses the subject matter of claims 4 through 11 and 13            
          through 16 on appeal.  In that regard, we again note that after             
          repeated use of the same icon for the exact same medication for a           
          sufficient period of time (e.g., weeks, months or years), we are            
          convinced that most users would come to recognize that icon as              
          identifying or describing a particular medication, its uses,                
          symptoms treated, results of its consumption, etc., without                 
          reference to another source.  Likewise, after such repeated use,            
          the icon itself would be understood as being descriptive of the             
          particular medication because of the fact that a long term user             
          would immediately make a mental association regarding the                   
          particular medication the icon represents.  We again make note              
          that appellants’s own specification, in the paragraph bridging              
          pages 6 and 7, supports this conclusion.                                    


               As has been made clear by our reviewing Courts on numerous             
          occasions, anticipation or lack of novelty is the ultimate or               
          epitome of obviousness.  See, in this regard, In re Fracalossi,             
          681 F.2d 792, 794, 215 USPQ 569, 571 (CCPA 1982); In re Pearson,            
                                          8                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007